Anastomotic leakage (AL) after colorectal surgery (CRS) is a serious postoperative complication that leads to intraabdominal sepsis. An accurate method for early prediction of AL has not been established, and it is usually diagnosed 6-12.7 days postoperatively.
Previous studies have explored various biomarkers for the early prediction of AL, such as markers of ischemia, microbiological biomarkers and inflammation parameters in drainage fluid, and serum markers. However, they all face challenges regarding accuracy and rapidity, and none have yet been put into practical use.
Measuring endotoxin (ET) a component of Gram-negative bacteria in drainage fluid may be useful for predicting AL by directly detecting leakage of gastrointestinal contents from anastomotic sites.
We previously reported that using an ET-specific limulus amebocyte lysate (LAL) reagents and measuring ET levels in drainage fluid collected 1-5 hours after CRS (POD0) via the recently developed endotoxin scattering photometry (ESP) assay allows for highly sensitive AL prediction. However, the ESP assay is not practical for clinical use. The turbidimetric assay using LIMUSAVE®, which is widely used in Japan, is clinically applicable. We present selected data from our findings.
ET values measured in POD0 drainage fluid using ET-specific LAL reagents suggest the potential for serving as a good predictor of AL after CRS. We consider the ability to utilize the clinically available LIMUSAVE® particularly significant.
抄録全体を表示